John Kirkwood, MD, PhD: There are 2 arenas. First, the measurable active disease where we can make correlations much quicker because those patients…
Archive | Video Reports
Using ctDNA to Monitor Patients With Melanoma
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Janku on the Efficacy of Ripretinib in KIT-Mutated Melanoma
Filip Janku, MD, PhD, discusses the results form a phase 1 study (NCT02571036) of ripretinib (Qinlock), a broad-spectrum KIT and PDGFRA inhibitor, in patients with KIT-mutated or KIT-amplified melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
Future Management of Uveal Melanoma
Richard D. Carvajal, MD: Marlana, this has been a great conversation. Let’s close with future directions.
Posted in Melanoma News, Health Professionals, Video Reports
Uveal Melanoma: Sequencing Therapy
Richard D. Carvajal, MD: You presented nice work trying to tease out the potential confounding effects of post-progression therapies.
Posted in Melanoma News, Health Professionals, Video Reports
 |
 |
 |
 |
